TME PHARMA ANNONCE LA PRSENTATION DUN POSTER PAR LE NATIONAL CANCER INSTITUTE AMRICAIN SUR LINHIBITION DE CXCL12 PAR NOX-A12 DANS LE GLIOBLASTOME A LA REUNION ANNUELLE DU SNO 2024
| JDVFX Fund | USD 23.37 0.31 1.34% |
Slightly above 50% of John Hancock's investors are presently thinking to get in. The analysis of overall sentiment of trading John Hancock Disciplined mutual fund suggests that some investors are interested at this time. John Hancock's investing sentiment can be driven by a variety of factors including economic data, John Hancock's earnings reports, geopolitical events, and overall market trends.
John |
TME Pharma N.V. , une socit de biotechnologie au stade clinique spcialise dans le dveloppement de nouvelles thrap
Read at businesswire.com
 |
John Hancock Fundamental Analysis
We analyze John Hancock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of John Hancock using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of John Hancock based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Year To Date Return
Year To Date Return Comparative Analysis
John Hancock is currently under evaluation in year to date return among similar funds. Year to Date Return (YTD) is the total return generated from holding a security from the beginning of the current fiscal year. In other words, YTD Return represents the capital appreciation of your investments from the start of the current fiscal year.
John Hancock Disciplined Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with John Hancock mutual fund to make a market-neutral strategy. Peer analysis of John Hancock could also be used in its relative valuation, which is a method of valuing John Hancock by comparing valuation metrics with similar companies.
Peers
John Hancock Related Equities
| TACLX | Touchstone Large | 1.49 | ||||
| TADGX | T Rowe | 1.45 | ||||
| GABFX | Gmo Asset | 0.97 | ||||
| GGRYX | Growth Allocation | 0.99 | ||||
| FMTIX | Franklin Moderate | 0.99 | ||||
| UPAAX | Upright Assets | 4.14 |
Other Information on Investing in John Mutual Fund
John Hancock financial ratios help investors to determine whether John Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in John with respect to the benefits of owning John Hancock security.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |